177 related articles for article (PubMed ID: 15495684)
1. [Analysis of latest trends in illegal drug consumption ].
Tabe M; Ito E; Kouno Y
Chudoku Kenkyu; 2004 Jul; 17(3):251-8. PubMed ID: 15495684
[No Abstract] [Full Text] [Related]
2. [The latest tendency of uncontrolled substance inquiries to JPIC].
Kuroki Y
Chudoku Kenkyu; 2004 Jul; 17(3):241-3. PubMed ID: 15495682
[No Abstract] [Full Text] [Related]
3. Illegal drug impersonators: the synthetic drug abuse boom.
Falkowski C
Minn Med; 2011 Oct; 94(10):52-4. PubMed ID: 23256286
[TBL] [Abstract][Full Text] [Related]
4. [Designer drugs in Finland].
Tacke U; den Hollander B; Simojoki K; Korpi ER; Pihlainen K; Alho H
Duodecim; 2011; 127(19):2027-36. PubMed ID: 22073534
[TBL] [Abstract][Full Text] [Related]
5. Market watch: sales trends by therapeutic area: 2008-2013E.
Goodman M
Nat Rev Drug Discov; 2009 Sep; 8(9):689. PubMed ID: 19721440
[No Abstract] [Full Text] [Related]
6. Generics offer pharmacy plans specific benefits.
Reinke T
Manag Care; 2010 Feb; 19(2):28-30, 34. PubMed ID: 20550049
[No Abstract] [Full Text] [Related]
7. Top 20 pharmaceutical companies. Ranked by U.S. sales, December 2005 to November 2006.
Mod Healthc; 2007 Jan; 37(2):33. PubMed ID: 17243346
[No Abstract] [Full Text] [Related]
8. BZP-party pills: a review of research on benzylpiperazine as a recreational drug.
Cohen BM; Butler R
Int J Drug Policy; 2011 Mar; 22(2):95-101. PubMed ID: 21242080
[TBL] [Abstract][Full Text] [Related]
9. A bad trip: lawmakers try to stay one step ahead of the chemists manufacturing dangerous synthetic drugs.
Lawrence A
State Legis; 2011 Jun; 37(6):28-9. PubMed ID: 21667572
[No Abstract] [Full Text] [Related]
10. [MHLW's countermeasures for uncontrolled substance and future tasks].
Yamamoto J
Chudoku Kenkyu; 2004 Jul; 17(3):245-50. PubMed ID: 15495683
[No Abstract] [Full Text] [Related]
11. By the numbers. Top 20 pharmaceutical companies. Ranked by U.S. sales, April 2003 through March 2004.
Moon S
Mod Healthc; 2004 Aug; 34(33):40. PubMed ID: 15356990
[No Abstract] [Full Text] [Related]
12. The role of pharmacies in the care of drug users: what has changed in ten years. The case of a Swiss region.
Samitca S; Huissoud T; Jeannin A; Dubois-Arber F
Eur Addict Res; 2007; 13(1):50-6. PubMed ID: 17172779
[TBL] [Abstract][Full Text] [Related]
13. Recent trends of drug abuse in Japan.
Yamamoto J
Ann N Y Acad Sci; 2004 Oct; 1025():430-8. PubMed ID: 15542746
[TBL] [Abstract][Full Text] [Related]
14. Solvent abuse trends in Japan.
Suwaki H
NIDA Res Monogr; 1995; 148():121-35. PubMed ID: 8929888
[No Abstract] [Full Text] [Related]
15. Drug production, trafficking and trade in Asia and Pacific Island countries.
Reid G; Devaney ML; Baldwin S
Drug Alcohol Rev; 2006 Nov; 25(6):647-50. PubMed ID: 17132580
[TBL] [Abstract][Full Text] [Related]
16. Canadian narcotic comsumption warrants government, pharmaceutical industry and professional study.
Wilson RG; Geekie DA
Can Med Assoc J; 1979 May; 120(10):1266-8. PubMed ID: 445271
[No Abstract] [Full Text] [Related]
17. [The Reverse Traffic of Drugs Phenomenon: experience in Galicia, Spain].
Vázquez-Mourelle R; Rodriguez Costa E; Pose Reino JM; Cadórniga Valiño L
Rev Esp Salud Publica; 2015 Oct; 89(5):431-45. PubMed ID: 26650469
[TBL] [Abstract][Full Text] [Related]
18. By the numbers. Top 20 pharmaceutical companies ranked by U.S. sales, November 2003 to October 2004.
Moon S
Mod Healthc; 2005 Jan; 35(1):32. PubMed ID: 15693520
[No Abstract] [Full Text] [Related]
19. WHO Expert Committee on Drug Dependence. Twenty-sixth Report.
World Health Organ Tech Rep Ser; 1989; 787():1-32. PubMed ID: 2555972
[No Abstract] [Full Text] [Related]
20. Distribution aspects in the potential misuse of O-T-C preparations.
Myers MJ
Am J Pharm Sci Support Public Health; 1970; 142(1):29-36. PubMed ID: 5514095
[No Abstract] [Full Text] [Related]
[Next] [New Search]
